+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proton Pump Inhibitor"

Erosive Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2024 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Antiulcerant Drugs: Global Markets to 2022 - Product Thumbnail Image

Antiulcerant Drugs: Global Markets to 2022

  • Report
  • May 2018
  • 185 Pages
  • Global
From
Global Omeprazole Market Outlook 2027 - Product Thumbnail Image

Global Omeprazole Market Outlook 2027

  • Report
  • May 2020
  • 104 Pages
  • Global
From
From
From
Loading Indicator

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea. PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers. Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more